Phoenix Financial Ltd. Trims Holdings in Agilent Technologies, Inc. $A

Phoenix Financial Ltd. cut its position in shares of Agilent Technologies, Inc. (NYSE:A) by 2.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,350 shares of the medical research company’s stock after selling 130 shares during the quarter. Phoenix Financial Ltd.’s holdings in Agilent Technologies were worth $513,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Stone House Investment Management LLC bought a new position in Agilent Technologies during the first quarter worth $30,000. Ransom Advisory Ltd bought a new position in Agilent Technologies during the first quarter worth $32,000. Central Pacific Bank Trust Division bought a new position in Agilent Technologies during the second quarter worth $33,000. Zions Bancorporation National Association UT bought a new position in Agilent Technologies during the first quarter worth $38,000. Finally, Costello Asset Management INC bought a new position in Agilent Technologies during the first quarter worth $47,000.

Analyst Ratings Changes

A has been the topic of several research analyst reports. Wells Fargo & Company raised their price objective on Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research note on Monday, September 15th. JPMorgan Chase & Co. raised their target price on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. Barclays raised their target price on Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a research note on Thursday, October 2nd. Finally, TD Cowen raised their target price on Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research note on Tuesday, October 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $149.62.

Agilent Technologies Stock Performance

A stock opened at $146.01 on Thursday. The stock has a market capitalization of $41.39 billion, a price-to-earnings ratio of 34.27, a PEG ratio of 4.76 and a beta of 1.26. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The stock’s fifty day moving average is $129.24 and its two-hundred day moving average is $118.56.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting analysts’ consensus estimates of $1.37. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same period last year, the company earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th were issued a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio (DPR) is 23.24%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.